Sinew Pharma Inc.

NT$55.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6634Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR 1.44%
Div yield —
ROE (10.85%)
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM 25.71%
Mkt cap NT$3.957B
ROIC (7.52%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$65
17.69%
12.69%
Hold 0|8|6|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.52
0.56
0.62
0.65
(3.93%)
7.92%
11.86%
18.09%
RevenueNT$M
344.2
337.9
355.0
359.1
1.34%
(2.58%)
2.19%
1.21%
Peers (US$116.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.927
0.595
0.527
EBIT/Intx
1.240
0.222
0.168
Own earn%
36.84
(111.03)
(110.12)
Sh yield%
25.72
5.04
7.53
Owners
Insiders/Inst%
14.61
57.24
Short interest%
4.94
SBC / revenue%
4.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
20–28
$1 testx
—
Incr. ROIC%
7